Moreover, pertinent studies have confirmed that cathepsin B consolidated the causative link between LPS and AD, and it’s anticipated that it will serve as a possible therapeutic target for avoiding AD initiation and pathological progression associated with periodontitis (101). The gene discussed is CTSB; the disease is Alzheimer disease.